MDL | - |
---|---|
Molecular Weight | 467.47 |
Molecular Formula | C27H21N3O5 |
SMILES | O=C(NC1)C2=C1C3=C4C5=C2C6=C(C=CC=C6)N5[C@](C[C@]7(O)C(OC)=O)([H])O[C@]7(C)N4C8=C3C=CC=C8 |
K-252a, a staurosporine analog, inhibits protein kinase , with IC 50 values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC , PKA , Ca 2+ /calmodulin-dependent kinase type II, and phosphorylase kinase, respectively [1] [2] . K-252a is a potent inhibitor (IC 50 of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene [3] .
CaMK II |
K-252a (3-100 nM, 8d) inhibits NGF-promoted neurite outgrowth [5] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Western Blot Analysis [4] .
Cell Line: | LINC00641-overexpressed cell line. |
Concentration: | 1.7 nM (NGF (50 ng/mL)). |
Incubation Time: | 6 h. |
Result: | Decreased p-Akt and p-TrkB levels. |
Cell Viability Assay [5] .
Cell Line: | PC12 subclone h cells. |
Concentration: | 3 to 100 nM. |
Incubation Time: | 8 d. |
Result: | Inhibited NGF-promoted neurite outgrowth. |
K252a (20 mg/kg/day) inhibiting TrkB pathway dampens the neuroprotective effects induced by TH [6] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Mice [6] . |
Dosage: | 20 mg/kg/day. |
Administration: | Intraperitoneally, daily, for consecutive 5 days. |
Result: | Dampened the neuroprotective effects induced by TH. |
Solid
Nocardiopsis sp.
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 50 mg/mL ( 106.96 mM ; Need ultrasonic and warming)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.1392 mL | 10.6959 mL | 21.3917 mL |
5 mM | 0.4278 mL | 2.1392 mL | 4.2783 mL |
10 mM | 0.2139 mL | 1.0696 mL | 2.1392 mL |
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.08 mg/mL (4.45 mM); Clear solution